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SUMMARY – Th e aim of the study was to determine the prevalence of metabolic syndrome 
 factors in obese children by examining blood pressure, lipid status, disorders of glycoregulation, and 
 parameters of insulin sensitivity and secretion. Th e survey was conducted as a cross sectional study. We 
analyzed the results of obese children aged 7 to 16 years visiting Clinical Centre of Montenegro 
 during the 2011-2015 period. Out of 173 children with elevated body mass index, 119 (68.8%) 
 children were overweight, while fi rst-degree obesity was recorded in 50 (28.9%) and second-degree 
obesity in four (2.3%) children. High blood pressure was found in 35.2%, elevated cholesterol levels in 
9.8% and elevated triglyceride levels in 8.09% of obese children. Oral glucose load testing revealed 
disturbing fasting glycemia in 4.76% and impaired glucose tolerance in 19.04% of obese children. 
High values of insulinemia two hours after glucose load were recorded in 35% of obese children. Study 
results showed the prevalence of risk factors for cardiovascular diseases and metabolic disorders, espe-
cially carbohydrates and fat, to be very high in our population of obese children. Th is imposes the need 
of changing current mode of assessing dietary habits during general medical examinations, as well as 
to start recording and monitoring overweight children and those with pronounced obesity.
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Introduction
Metabolic syndrome takes one of the key positions 
in contemporary medicine research because of signifi -
cant increase in the rate of morbidity of cardiovascular 
diseases. Most authors accept the recommendations 
for diagnosing metabolic syndrome, according to 
which the basic elements of the syndrome are central 
type of obesity, insulin resistance and intolerance of 
glucose, atherogenic dyslipidemia and arterial hyper-
tension1. In 2007, the International Diabetes Federa-
tion (IDF) defi ned the criteria for the risk of meta-
bolic syndrome development in children with the in-
tention to estimate the risk of diabetes mellitus type 2 
(T2DM) and cardiovascular disease by early identifi -
cation of the children at risk of metabolic syndrome 
development. According to these criteria, the diagno-
sis of metabolic syndrome cannot be established at the 
age of 6-10 years. In this age group, additional moni-
toring is required if there is positive family history of 
metabolic syndrome, T2DM, cardiovascular diseases 
and dyslipidemia. Th e criteria for metabolic syndrome 
in children aged 10-16 years include waist obesity 
(waist circumference ≥90% or lower limit for adults, if 
lower), triglycerides ≥1.7 mmol/L, high-density lipo-
protein (HDL) cholesterol <1.03 mmol/L, glycemia 
≥5.6 mmol/L or T2DM (if glycemia is ≥5.6 mmol/L, 
oral glucose tolerance test (OGTT) should be done), 
systolic blood pressure ≥130 mm Hg or diastolic ≥85 
mm Hg). In children older than 16, we use the IDF 
criteria for adults.
Th e android type of obesity in childhood has been 
shown to imply greater risk of cardiovascular disease in 
adulthood than gynoid type. Th is has been demon-
strated among children and adolescents by proving the 
association of visceral fat with high triglycerides and 
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lowered HDL cholesterol, as well as high blood pres-
sure. Th ese consequences do not depend on the per-
centage of total body fat. Th e mechanism by which it 
results in a higher risk of cardiovascular disease and 
visceral fat increase has not yet been fully clarifi ed but 
it is probably associated with insulin resistance, corti-
sol and adipocyte hormones2.
Reaven3 was the fi rst to describe syndrome X in the 
context of association of metabolic risk factors and 
diseases. Reaven has formulated his concept of the 
syndrome on the basis of the potentially harmful ef-
fects of insulin resistance, describing it as “the lower 
takeover of glucose by the means of insulin”. Current 
understanding of syndrome X implies its emergence 
from insulin resistance, while at the same time there is 
an increased risk of atherosclerotic disease and T2DM4. 
Hyperinsulinemia, the primary characteristic of syn-
drome X, occurs as the result of increased resistance to 
the action of insulin, which is associated with insulin 
full depots. Insulin resistance impairs glucose disposal, 
thus sugar remains in the blood, along with excess of 
fat in the liver. Studies have shown that obese people 
have a higher risk of developing insulin resistance 
compared to thin people. Syndrome X is also known 
as a metabolic cardiovascular syndrome and athero-
thrombogenic syndrome5. It has been proven that 
metabolic syndrome emerges in childhood but is more 
pronounced in obese children. About 30% of obese 
children have metabolic syndrome and 9 of 10 obese 
children have at least one component of the metabolic 
syndrome6.
Early detection of the risks that lead to the devel-
opment of metabolic syndrome among children is very 
important for their later life. Th e syndrome is ever 
more present among children; the National Health 
and Nutrition Examination Survey7 found its preva-
lence to be 6.4% at the end of 2000 in comparison to 
4.2% in 1992 (p<0.001). By tracking disorders of glu-
cose tolerance and insulin levels in obese children, in 
his doctoral dissertation Bojović8 stresses that obesity 
in childhood implies the risk of metabolic disturbance 
of carbohydrates and fat that might manifest as T2DM 
later in life. Th e author came to such a conclusion by 
comparing the results of a large survey of obese chil-
dren (N=312) and normal weight children aged 7-14 
years. On OGTT, the obese children had a statistically 
signifi cantly greater disturbance of glucose tolerance 
(impaired glucose tolerance (IGT), 1.28%) and base-
line insulin levels (15.8 IU/mL) in comparison to age-
matched normal weight children that had normal glu-
cose tolerance and baseline insulin levels (13.3 IU/
mL). Also, it was found that the percentage of boys 
with higher free fatty acid level increased signifi cantly 
with the increasing degree of obesity.
Atherosclerosis characterized by the blood vessel 
walls losing elasticity and muscle tissue being replaced 
by fi brous tissue and sometimes calcifi ed plates, is the 
culmination of lipid deposition in damaged blood ves-
sel walls throughout life, and not just over the last few 
years or only in old age. Atherosclerosis is in tight con-
nection with metabolic lipid disturbance, although the 
impact of all other factors that damage blood vessel 
walls is indisputable, with special emphasis on heredi-
tary factor that is transmitted from generation to gen-
eration.
Elevated concentration of cholesterol is of special 
importance in the development of atherosclerosis. Th e 
fat material, especially the cholesterol circulating 
through the blood vessels, is deposited in the walls of 
arterial blood vessels, in particular at the sites of their 
branching.
Th e high levels of low-density lipoprotein (LDL) 
cholesterol mainly and dominantly increase the risk of 
coronary disease. People with hereditary hypercholes-
terolemia who have defi ciency of LDL receptors that 
implies inability of cholesterol breakdown are at risk of 
coronary disease. In the early process of atherogenesis, 
damaged cells pass through monocytes-macrophages 
and LDL is infi ltrated in the subepithelial space. LDL 
that are oxidized by an unknown mechanism absorb 
the macrophages, forming the so-called foam cells. 
With further processes of the lesions, fat strips and ac-
cumulation of elastic tissues, proliferation of fi brin le-
sions, necrosis and foaming muscular cells and de-
struction of the layer that covers endothelial cells of 
induction and the formation of the thrombus and cal-
cifi cation, the atherogenesis process comes to an end. 
People with low levels of LDL cholesterol have pros-
pects for a long life. Reduction of the LDL cholesterol 
level diminishes the atherosclerotic risk9. High-densi-
ty lipoprotein is negatively correlated with cardiovas-
cular disease. Th e protective eff ect of HDL cholesterol 
levels is demonstrated when the LDL is high10.
Th e prevalence of vascular diseases is also high in 
people with high triglyceride levels, especially hyperli-
poproteinemia of inherited type.
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Th e aim of the study was to determine general and 
specifi c prevalence of the factors of metabolic syn-
drome among obese children. Evaluating the results, 
we want to point to the importance of metabolic syn-
drome in childhood for later development of cardio-
vascular and metabolic diseases.
Subjects and Methods
Th e survey was carried out in the form of a cross 
sectional study and analyzed children aged 7 to 16 
years tested at Clinical Department of Endocrinology, 
Institute for Childhood Diseases of Montenegro in 
Podgorica during the period from February 14, 2011 
to February 14, 2015. Th e survey included 173 obese 
children with high body mass index (BMI) values, di-
vided into 3 groups as follows: overweight (BMI 25.0-
29.9); fi rst-degree obesity (BMI 30.0-34.9); second-
degree obesity (BMI 35.0-39.9); and third-degree 
obesity (BMI ≥40.0).
For setting the diagnosis of metabolic syndrome, 
we used the IDF criteria from 2006. Waist size was 
measured by plasticized meter that cannot stretch. 
Waist size was expressed in centimeters with one deci-
mal. Blood pressure was measured with a mercury ma-
nometer with cuff  appropriate for each child’s age. Th e 
levels of cholesterol, HDL cholesterol, LDL choles-
terol and triglycerides were determined at Central 
Laboratory of the Clinical Centre in Podgorica. For 
cholesterol and its fractions, the enzymatic method of 
high specifi city was employed. Triglycerides were de-
termined by the enzymatic method with the appropri-
ate test reagent. OGTT was performed according to 
the WHO diabetes criteria from 1999. Th e values of 
glycemia and insulin were determined in fasting state 
and 2 hours post-load with 1.75 g glucose per kilogram 
body weight. C-peptide was determined only in fast-
ing state. Radioimmunoassay of insulin and C-peptide 
was performed in Radioisotope Laboratory of the 
Clinical Centre in Podgorica. Interpretation of glyce-
mia value was based on the WHO recommendations 
from 1999. Th e sample for lipid status monitoring in-
cluded 173 obese children. Th e sample for glycemia 
monitoring, insulin and C-peptide during OGTT in-
cluded 21 obese children randomly selected among 
173 obese children (12.1%).
Results
Out of 173 obese children, 119 (68.8%) were over-
weight, 50 (28.9%) with fi rst-degree obesity and four 
(2.3%) with second-degree obesity. Among overweight 
children and those with fi rst-degree obesity, there were 
signifi cantly more girls, while among children with sec-
Table 1. Specifi c risk factors of metabolic syndrome among obese children according to the degree 
of obesity
Risk factor Overweightn (%) 






BMI 119 (68.7) 50 (28.9) 4 (2.3) 173 (100.0)
Waist size
>P90 117 (98.3) 49 (98.0) 4 (100.0) 170 (98.2)
Blood pressure
>130/85 mm Hg 39 (32.8) 21 (42.0) 1 (25.0) 61 (35.2)
Cholesterol
>5.06 12 (10.1) 5 (10.0) - 17 (9.8)
HDL cholesterol
<1.03 mmol/L - 2 (3.8) 3 (75.0) 5 (2.3)
LDL cholesterol 
>3.4 mmol/L 24 (20.2) 12 24.0  2 (50.0) 38 (21.9)
Triglycerides
>1.7 mmol/L 7 (5.9) 7 14.0  - 14 (8.1)
BMI = body mass index; waist size >P90 = waist size more than 90th percentile; HDL = high-density lipoprotein; LDL 
= low-density lipoprotein
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ond-degree obesity the number of girls and boys was 
equal. Increased waist circumference was recorded in 
170 (93.3%), elevated blood pressure in 61 (35.3%), in-
creased cholesterol in 17 (9.8%), increased triglycerides 
in 14 (8.1%) and high LDL cholesterol levels in 38 
(21.9%) study children. Th e value of LDL cholesterol 
was found to rise with the degree of obesity. Lower lev-
els of HDL cholesterol were found in fi ve (23.8%) of 21 
obese children. Th e percentage of children with low 
HDL cholesterol levels (<1.03 mmol/L) increased with 
the degree of obesity (0 in overweight children, 33.3% 
in children with fi rst-degree obesity and 75% in those 
with second-degree obesity) (Table 1).
In 21 obese children, glycemia and insulin were 
monitored in fasting state and 2 hours post-loading 
with glucose, and C-peptide in fasting state; their re-
sults are shown in Table 2. Fasting glycemia <6.1 
mmol/L was recorded in 20 (95.2%) children, im-
paired fasting glucose in one (4.76%) female child 
with fi rst-degree obesity, and IGT in four (19.04%) 
children including three children with second-degree 
obesity and one with fi rst-degree obesity. During 
OGTT, none of them had the values of fasting glyce-
mia and 2 hours post-load typical for diabetes.
High baseline insulin level was recorded in one 
(4.76%) child with fi rst-degree obesity. Baseline C-
peptide levels were within the normal limits in all 
study children.
Monitoring the mean values of glycemia and insu-
lin during OGTT revealed some signifi cant results 
(Table 3). Th e values of glycemia and insulin 2 hours 
post-load rose with the degree of obesity. Th ere were 
no signifi cant diff erences in the values of C-peptide 
among the children according to the degree of obesity.
Discussion
In the present study, we monitored the prevalence 
of certain factors of metabolic syndrome, possible dis-
Table 2. Glycemia, insulin and C-peptide during oral glucose tolerance test (OGTT), baseline (0) 
and 2 hours post-load (2 h) in 21 obese children 








 1 M I D.I. 5.1; 6.5 14.0 88.9 0.75
 2 F I Lj.Lj. 5.3 5.7 14.8 24.1  0.71
 3 M I B.B. 4.4 6.8 10.5 172.9 0.63
 4 M I L.M. 5.8 3.5 13.3 77.4 0.71
 5 M I P.I. 5.4 6.4 9.4 59.1 0.74
 6 F I M.E. 5.2 7.1 10.1 77.9 0.6
 7 F I S.M. 4.5 6.3 11.8 64.4 0.85
 8 F I L.T. 5.3 6.4 11.5 68.9 0.79
 9 M I R.A. 5.3 6.4 18.2 69.7 0.73
10 F I S.I. 5.6 7.1 17.1 68.9 0.74
11 M I A.M. 5.4 7.8 16.9 79.8 0.71
12 M II A.N. 5.0 6.9 14.0 95.9 0.91
13 F II K.M. 5.7 7.7 21.1 116.6 1.20
14 F II J.E. 5.8 7.3 26.7 180.5 0.83
15 F II Z.B. 5.6 6.2 18.1 79.8 0.74
16 F II J.I. 5.3 6.9 17.9 104.2 0.79
17 F II I.A. 6.1 7.9 17.4 128.3 0.62
18 M III Z.V. 5.0 9.4 9.4 59.1 0.74
19 F III G.T. 5.1 8.6 11.0 206.9 0.58
20 M III I.M. 5.4 9.7 16.1 253.o 0.9
21 M III P.L. 4.8 7.1 15.0 91.5 0.7
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orders of glycemia, insulin and C-peptide levels during 
OGTT in obese children. Out of all the factors of 
metabolic syndrome among obese children, the most 
frequent were the increase of waist size above 90th per-
centile (P90) (98.2%), high blood pressure (35.2%), 
lowered HDL (23.8%) and high LDL cholesterol 
(21.0%). Besides the predominant increase in waist 
size, it means that every third obese child had high 
blood pressure and every fi fth child had high LDL 
cholesterol. High total cholesterol (9.8%) and triglyc-
erides (8.1%) were found in a signifi cantly smaller per-
centage of obese children.
Waist obesity is the fi rst factor of metabolic syn-
drome in childhood according to the order of manifes-
tation, then inducing a chain of metabolic processes 
that result in metabolic syndrome. Layers of adipose 
tissue on the stomach lead to higher excretion of fatty 
acids in liver circulation and higher fat in the blood, 
also serving as a source of diff erent hormones (adipo-
kines) that are involved in the development of insulin 
resistance. In this study, it was indicated by high LDL 
cholesterol. Obesity is accompanied by reduction in 
the number and sensitivity of specifi c insulin receptors 
on target cells. Cells become insensitive to insulin and 
a relatively small amount of glucose is dissolved, the 
level of blood glucose rises, which further stimulates 
the pancreas to higher secretion of insulin. On the 
contrary, weight reduction associated with limited cal-
orie input and physical activity improves insulin sensi-
tivity7. Insulin resistance is defi ned as a response to 
lower than normal insulin that leads to hyperinsu-
linemia in an attempt to maintain normal glucose lev-
els. Th erefore, hyperinsulinemia due to the higher be-
ta-cell secretion is one of the main accompanying fea-
tures, along with insulin resistance. Th e main charac-
teristics of insulin resistance are poor inhibition of 
gluconeogenesis, disturbed glucose uptake in the mus-
cles and poor inhibition of adipose tissue lipolysis8.
Th e results of our survey indicated the state of in-
sulin resistance to be accompanied by higher insulin 
secretion during OGTT. At 2 hours post-load, hyper-
insulinemia increased signifi cantly with the degree of 
obesity. In obese children, insulin resistance and hy-
perinsulinemia are accompanied by changes in glucose 
tolerance during OGTT, expressed as impaired fasting 
glucose and IGT. IGT during OGTT, with high val-
ues of glycemia, but still not so high to be character-
ized as diabetes, was present in 19.04% of obese chil-
dren. Th e second possible characteristic of metabolic 
syndrome is impaired fasting glucose; in our study, no 
case of diabetes was recorded during OGTT. Th is 
means that there was no reduction of plasma insulin 
due to beta-cell decomposition, and no hyperglycemia 
and lipid disorder indicating metabolic syndrome pro-
gression to diabetes. Anyhow, it is a slow process that 
will not manifest in childhood but remains as a risk for 
development of T2DM in obese children in adult-
hood. In our country, this fact was pointed out by 
Bojović as early as 198011. As for the question whether 
IGT or impaired fasting glucose occurs fi rst in the de-
velopment of metabolic syndrome, we consider that 
IGT occurs fi rst12. Th is conclusion is drawn from the 
fact that IGT is present at a much higher percentage 
in obese children than impaired fasting glucose. Nu-
Table 3. Most relevant results obtained by monitoring pooled (mean) glycemia (Gl) and insulin (Ins) levels during oral 
glucose tolerance test (0, baseline; 2, 2 h post-load)
Minimum Maximum  Mean Standard deviation
Degree of obesity n Gl 0 Gl 2 Gl 0 Gl 2 Gl 0 Gl 2 Gl 0 Gl 2
I 11 4.4 3.5 5.8 7.8 5.21 6.36 0.421 1.096
II 6 5.0 6.2 6.1 7.9 5.58 7.15 0.387 0.619
III 4 4.8 7.1 5.4 9.7 5.08 8.7 0.25 1.163
Minimum Maximum Mean Standard deviation
Degree of obesity n Ins 0 Ins 2 Ins 0 Ins 2 Ins 0 Ins 2 Ins 0 Ins 2
I 11 9.4 24.1 18.2 172.9 13.42 77.46 3.046 35.787
II 6 14.0 79.8 26.7 180.5 19.2 117.5 4.314 35.075
III 4 9.4 59.1 16.1 253 12.875 156.6 3.189 92.203
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merous epidemiological studies in the world13-16 and 
two in Montenegro17 show that obesity in childhood 
takes on epidemic proportions. Taking into account 
this fact, it is necessary to determine the prevalence of 
metabolic syndrome among obese children, as it is ob-
viously on increase18. It should be noted that the prev-
alence of metabolic syndrome, and especially of some 
specifi c elements of metabolic syndrome, increases 
with the degree of obesity19.
Th e existing program and the mode of evaluating 
nutritional status on systematic examinations of chil-
dren do not enable setting the diagnosis of early disor-
ders of overweight and degree of obesity. With the 
new approach, it should be possible to enter data on 
BMI during systematic examinations of children.
Conclusion
Th e presence of risk factors for cardiovascular dis-
eases and metabolic disorders, especially carbohydrates 
and fat, is very high in the population of obese chil-
dren. Th erefore, early recognition of genetic factors 
and environmental factors, as well as of combinations 
of risk factors for metabolic syndrome among obese 
children and adolescents is of utmost importance. To 
this end, there is a need for monitoring of lipid status 
and glucose tolerance among obese children, especially 
those with waist type of obesity.
It is necessary to determine and monitor BMI once 
a year among children and adolescents so as to identify 
obesity on time and prevent its harmful infl uence. Th is 
imposes the need to change the current method of as-
sessment of nutritional status of children during sys-
tematic examinations, as well as registration and fol-
low up of the children with overweight and pro-
nounced obesity.
In addition to the necessary preventive measures to 
reduce obesity as a risk factor that can lead to serious 
metabolic disorders, early detection of the presence of 
individual or associated parameters of the metabolic 
syndrome in obese children is necessary.
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Sažetak
UČESTALOST KARDIOVASKULARNIH ČIMBENIKA RIZIKA U PRETILE DJECE
L. Rakočević i V. Rakočević
Cilj studije bio je odrediti učestalost pojedinačnih čimbenika metaboličkog sindroma kod pretile djece ispitujući krvni 
tlak, lipidni status, poremećaje glikoregulacije, parametre inzulinske osjetljivosti i lučenja. Istraživanje je provedeno u obliku 
poprečne studije. Analizirani su rezultati pretile djece u dobi od 7 do 16 godina u Kliničkom Centru Crne Gore u razdoblju 
od 2011. do 2015. godine. Od 173 djece s povišenim indeksom tjelesne mase, 119 (68,8%) ih je imalo prekomjernu težinu, 
50 (28,9%) 1. stupanj pretilosti i četvoro djece (2,3%) 2. stupanj pretilosti. Povišen krvni tlak imalo je 35,2%, povišene vrijed-
nosti kolesterola 9,8% i povišene vrijednosti triglicerida 8,09% pretile djece. Tijekom oralnog opterećenja glukozom poreme-
ćenu glikemiju natašte imalo je 4,76%, a poremećenu toleranciju glukoze 19,04% pretile djece. Povišene vrijednosti insuline-
mije dva sata poslije opterećenja glukozom imalo je 35% pretile djece. Zastupljenost čimbenika rizika za kardiovaskularne 
bolesti i metaboličke poremećaje, naročito ugljikohidrata i masti, u populaciji pretile djece je veoma visoka. To nameće potre-
bu izmjene sadašnjega načina procjene uhranjenosti djece pri sistematskim pregledima, kao i registriranja i praćenja djece s 
prekomjernom tjelesnom težinom i izraženom pretilosti.
Ključne riječi: Metabolički sindrom X; Pretila djeca; Rizični čimbenici; Učestalost
